Clinical trial
Challenge Dose Administration of Twinrix™ or Comparator 4 Years After Primary Vaccination.
NCT00684671 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Challenge Dose Administration of Twinrix™ or Comparator 4 Years After Primary Vaccination.
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 26, 2008
- Completion date
- November 3, 2008
- Enrollment
- 506 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.